Merck KGaA and Millipore Announce Transaction - Video Interview with Merck CEO

LONDON, March 1, 2010 - Merck, the global pharmaceutical and chemical company, announced it is to
acquire all outstanding shares of Millipore, the US life sciences company,
for US$ 107 per share in cash, or a total transaction value, including net
debt, of approximately EUR 5.3 billion (US$ 7.2 billion), creating a
world-class partner for the life science sector.

In a video interview on broadcaster www.cantos.com,
Dr Karl-Ludwig Klay, Merck Chief Executive, said the transaction was
"truly transformational" for Merck's Chemicals business.

"We believe that the acquisition is very compelling and fully in line
with our strategy."

The interview and transcript are available now on
www.cantos.com/company/merck.

Cantos.com, the online financial broadcaster, features in-depth
interviews, documentaries and webcasts with senior company executives. If
you would like to contact us, please email amanda.alexander@cantos.com or
phone +44-207-936-1352.

If you would like to contact us, please email amanda.alexander at cantos.com or
phone +44-207-936-1352.